Download DNB 2016 Dec HEMATOLOGY PAPER 2 Question Paper

Download Diplomate of National Board (DNB) 2016 Dec HEMATOLOGY PAPER 2 Previous Question Paper

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY

PAPER ? II
HEMAT/D/16/48/II
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) What are the causes of lymphocytosis?
b) What are the causes of lymphocytopenia?
c) How do you test for clonality of viruses that can cause
lymphocytosis?

3+3+4
2. a) Enumerate the diseases where iron overload has an impact.
b) Tests and procedures to estimate iron overload.
c) Treatment options for iron overload.

3+3+4
3. a) What are blood component?
b) How do you prepare them?
c) How do you use blood components in critically ill patients?

3+3+4
4. a) What are transfusion related complications?
b) Problems and solutions in immune cytopenias: Role of
transfusion of blood products.
c) Principles of blood compatibility testing.

4+3+3
5. In CLL:
a) What are the stages and prognosis?
b) What is the preferred treatment for younger patients?
c) What are the options for untreated older patients?

3+3+4
6. In a bone marrow study, explain with examples the importance of:
a) Bone marrow aspirate.
b) Bone marrow biopsy.
c) Special tests on aspirate.
d) Special tests on biopsy.
e) Technical issues in the bone marrow aspirate and biopsy.






2+2+2+2+2










P.T.O.
FirstRanker.com - FirstRanker's Choice
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY

PAPER ? II
HEMAT/D/16/48/II
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) What are the causes of lymphocytosis?
b) What are the causes of lymphocytopenia?
c) How do you test for clonality of viruses that can cause
lymphocytosis?

3+3+4
2. a) Enumerate the diseases where iron overload has an impact.
b) Tests and procedures to estimate iron overload.
c) Treatment options for iron overload.

3+3+4
3. a) What are blood component?
b) How do you prepare them?
c) How do you use blood components in critically ill patients?

3+3+4
4. a) What are transfusion related complications?
b) Problems and solutions in immune cytopenias: Role of
transfusion of blood products.
c) Principles of blood compatibility testing.

4+3+3
5. In CLL:
a) What are the stages and prognosis?
b) What is the preferred treatment for younger patients?
c) What are the options for untreated older patients?

3+3+4
6. In a bone marrow study, explain with examples the importance of:
a) Bone marrow aspirate.
b) Bone marrow biopsy.
c) Special tests on aspirate.
d) Special tests on biopsy.
e) Technical issues in the bone marrow aspirate and biopsy.






2+2+2+2+2










P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-2-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY

PAPER ? II


7. a) Classify Hodgkin?s disease.
b) Staging of Hodgkin?s disease.
c) PET/CET adapted treatment in Hodgkin?s disease.
d) Fertility preservation in Hodgkin?s disease survivors.

2+2+4+2
8. In survivors of non- Hodgkin?s lymphoma, what are the strategies
for:
a) Monitoring for relapse
b) Monitoring for complications
c) Maintenance therapy

4+4+2
9. In febrile neutropenia:
a) How do you assess risk?
b) Importance of fungal markers.
c) Importance of imaging.

4+3+3
10. In pregnancy and thrombosis:
a) How do you choose anti-coagulants in first trimester?
b) How do you manage heparin induced thrombocytopenia?
c) Advice at labour and delivery.

4+3+3
**********************
FirstRanker.com - FirstRanker's Choice